These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events. Levy Y, Shenkman B, Tamarin I, Pauzner R, Shoenfeld Y, Langevitz P, Savion N, Varon D. Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349 [Abstract] [Full Text] [Related]
6. Persistency of low levels of anticardiolipin and anti-beta2 glycoprotein1 in thrombosis. Amaral M, Favas C, Delgado Alves J. Eur J Intern Med; 2010 Apr; 21(2):101-3. PubMed ID: 20206880 [Abstract] [Full Text] [Related]
7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E. Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [Abstract] [Full Text] [Related]
8. An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS). Pontara E, Cheng C, Cattini MG, Bison E, Pelloso M, Denas G, Pengo V. Lupus; 2019 Dec; 28(14):1663-1668. PubMed ID: 31701800 [Abstract] [Full Text] [Related]
9. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N. Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474 [Abstract] [Full Text] [Related]
10. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC. Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297 [Abstract] [Full Text] [Related]
12. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. Forastiero R, Martinuzzo M, Carreras LO, Maclouf J. Thromb Haemost; 1998 Jan; 79(1):42-5. PubMed ID: 9459320 [Abstract] [Full Text] [Related]
13. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Persijn L, Decavele AS, Schouwers S, Devreese K. Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896 [Abstract] [Full Text] [Related]
14. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W, Matthias T, Scharrer I. Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [Abstract] [Full Text] [Related]
15. [Association between antiphospholipid antibodies and arterial or venous thrombosis/thrombocytopenia]. Nojima J, Suehisa E, Kuratsune H, Amino N. Rinsho Byori; 1998 Dec; 46(12):1181-7. PubMed ID: 9916502 [Abstract] [Full Text] [Related]
16. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome]. Fujieda Y, Shida H, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T. Nihon Rinsho Meneki Gakkai Kaishi; 2014 Dec; 37(5):430-6. PubMed ID: 25744643 [Abstract] [Full Text] [Related]
19. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies. Musiał J, Swadźba J, Jankowski M, Grzywacz M, Bazan-Socha S, Szczeklik A. Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980 [Abstract] [Full Text] [Related]